Posts Tagged ‘Chance’

‘I’m still here today’: Cancer screenings, self care gives survivors best chance

‘I’m still here today’: Cancer screenings, self care gives survivors best chance
BAMBERG — Cancer survivors, caregivers, friends and supporters gathered for the 13th annual Bamberg County Best Chance Task Force Educational Luncheon recently. Nearly 200 attended the event, which was hosted by the Bamberg Job Corps Center.

Read more on The Times and Democrat

You Docs: There’s still a good chance that hormone therapy can help you

You Docs: There’s still a good chance that hormone therapy can help you
What are the newer, safer forms? Bioidentical estrogen (estradiol) and micronized progesterone, which doesn’t block estrogen’s artery-pampering effects.

Read more on The Oregonian

Active Lifestyle Reduce Chance on Breast Cancer

Sometimes the immediate benefits of exercise – extra energy or a sense of accomplishment – are better motivation to exercise than long-term gains such as protection against chronic diseases. But, whatever the incentive, being physically active throughout one’s life is good for health. Canadian researchers recently added further support to a long-term benefit of exercise for women with some new findings that a lifetime of physical activity may minimize the risk of developing breast cancer.

An active lifestyle reduces possibly the chance on hereditary udder cancer. That is the provisional conclusion of the test book of Anouk Pijpe, research worker at Dutch cancer institute.
Women who are charged with the hereditary genetic deviation in BRCA1 or BRCA2 the gene have 6 up to 8 a time larger chance on getting udder cancer then women without this hereditary construction. A slightly brought back by moving sufficiently and healthy body weight seems be able this become risk.

That a healthy lifestyle reduces the risk on udder cancer for the general population it had been already rather shown. The research of Anouk Pijpe shows that this applies also to women with hereditary udder cancer (BRCA 1 and 2).

Anouk Pijpe give a step in the good direction to its research – of the first in its type – to that are, but that we there still long are not: `It is still too early for specific recommendations. For that follow-up studies are necessary. Up to that time the most important message to BRCA1/2 mutation-carry-delicate is that the recommendations apply such as those in general applying, certainly also for them.

Before you go anywhere visit http://www.weightlossinfo4u.co.cc or http://www.healthresource4u.com For All Types Of Health Related issue shuch as Weightloss tips,Skin cure,Hair Style Etc.

When Doctors Do Not Follow Up After PSA Results Signal The Chance Of Prostate Cancer

Male patients frequently possess a poor knowledge of prostate cancer, their own chances for the cancer, and how to determine whether they have prostate cancer. Many men have little, if any, knowledge of the advantage of screening for prostate cancer or of the guidelines for when to start screening, how frequently to screen, and the meaning of screening test results. They put their confidence in their physician to do whatever is appropriate to detect any cancer early and cure them.

Delayed diagnosis of prostate cancer incidents are all too common. One typical medical mistake that is at the root of these cases arises when the male patient’s primary care physician (1) actually screens the individual for prostate cancer by tracking the amount of PSA (Prostate Specific Antigen) in his system, (2) finds abnormally high levels of PSA and but (3) does not inform the patient, does not refer the patient to a specialist, and fails to get a biopsy to confirm whether the elevated PSA is a result of prostate cancer. The lawsuit below illustrates this situation.

A physician, an internist, discovered that his male patient had a PSA of 8. (anything above a 4.0 is normally viewed as high). The physician did not inform the patient. The physician did not refer the patient to a urologist. The doctor did not order a biopsy. Two years later the doctor repeated the PSA test. This time it had gone up to 13.6. Again, the doctor said nothing to the patient. Again, the doctor did not refer the patient to a urologist. And again, the physician did not order a biopsy. Two years later the doctor repeated the PSA test. It was not until three years after first finding out about the patient’s elevated PSA level that the physician at last advised him that he probably had cancer. Further testing showed that at this point he had metastatic prostate cancer. A prostatectomy was no longer an option. Treating physicians alternatively recommended radiation therapy and hormone therapy. Neither of these would cure the cancer but they might impede the cancer’s advancement and further spread. The law firm handling this matter reported that the case proceeded to mediation and settled in the amount of $600,000.

But not following up after observing abnormal test results brings about a situation in which those patients who do actually have prostate cancer might not find out they have it until it has spread outside the prostate, decreasing the patient’s choices for treatment, and substantially reducing the chances that the patient will be able to survive the cancer.

As the above claim illustrates physicians sometimes comply with the guidelines by performing screening for prostate cancer yet when the test results are abnormal they fail to do anything about it.

When Physicians Fail To Follow Up After PSA Results Indicate The Chance Of Prostate Cancer

Men often possess a lack of awareness of prostate cancer, their own risk for the cancer, and how to determine whether they have prostate cancer. Most male patients do not even know what it means to test for prostate cancer or that screening should be done before they develop symptoms. Yet, far too often, doctors diagnose the cancer only after it is past the early stages on account of deficient of screening.

There are several different factors that might result in a delayed diagnosis. This article will analyze the following pattern: the doctor (1) orders a PSA blood test, (2) discovers that the individual has an elevated PSA level, but (3) neither informs him of abnormal results (and what they indicate) nor orders diagnostic tests, like a biopsy, to rule out prostate cancer. Examine the following lawsuit, for instance:

In this reported case a male patient discovered he had prostate cancer after he followed up when told by his internist that he most likely had cancer. The problem in this case was that the internist did not tell the patient that he might have cancer until the third year of elevated PSA test results. The year before the man’s PSA level had increased to 13.6. Two years prior to that it had been at 8.0 Throughout these years the physician took no action to rule out prostate cancer as the cause of these high readings and did not tell the patient. By the time he was diagnosed he had metastatic prostate cancer and surgery was no longer among the treatment alternatives. Treating doctors instead recommended radiation therapy and hormone therapy. Neither of these would eliminate the cancer but they might impede the cancer’s progress and further spread. The law firm that handled this matter reported that they took the case to mediation where they achieved a settlement of $600,000.

When they do not do anything in the presence of abnormal test results and the man subsequently learns that he had prostate cancer and that the delay lead to it growing outside the prostate therefore limiting treatment alternatives and lessening his likelihood of surviving the cancer, he might have a claim for medical malpractice against the doctor.

This case illustrates a type of mistake that can lead to the delayed diagnosis of a patient’s prostate cancer. It comes about when the doctor actually follows the guidelines and screens male patients for prostate cancer but does not follow through when the test results are abnormal.